A Japan-based pharmaceutical manufacturer focused on developing and commercializing prescription medicines across oncology, urology, immunology, and rare diseases. The company generates significant revenue from global therapies such as Xtandi for prostate cancer and continues to invest heavily in cl...
3 members of Congress have disclosed 13 trades in Astellas Pharma Inc. (ALPMY), a Healthcare company. The buy/sell breakdown shows 8 purchases versus 5 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-07-10 | Daniel Goldman | sell | $15K – $50K |
| 2023-02-27 | Daniel Goldman | buy | $15K – $50K |
| 2023-01-13 | Daniel Goldman | sell | $1K – $15K |
| 2020-03-18 | Greg Gianforte | buy | $15K – $50K |
| 2018-11-19 | Greg Gianforte | sell | $1K – $15K |
| 2018-03-26 | Greg Gianforte | buy | $1K – $15K |
| 2017-05-10 | Thomas MacArthur | sell | $15K – $50K |
| 2017-01-10 | Thomas MacArthur | buy | $1K – $15K |
| 2017-01-09 | Thomas MacArthur | buy | $15K – $50K |
| 2016-12-07 | Thomas MacArthur | sell | $15K – $50K |
| 2016-09-20 | Thomas MacArthur | buy | $1K – $15K |
| 2016-07-27 | Thomas MacArthur | buy | $1K – $15K |
| 2016-07-26 | Thomas MacArthur | buy | $15K – $50K |